|
| | (5Z,11Z,14Z)-8,9-dihydroxyicosa-5,11,14-trienoic acid Basic information |
| Product Name: | (5Z,11Z,14Z)-8,9-dihydroxyicosa-5,11,14-trienoic acid | | Synonyms: | (5Z,11Z,14Z)-8,9-dihydroxyicosa-5,11,14-trienoic acid;(5E,11E,14E)-8,9-dihydroxyicosa-5,11,14-trienoic acid;8,9-Dihydroxyeicosatrienoic acid;(±)8,9-DHET;(±)8(9)-DiHET;DCJBINATHQHPKO-TYAUOURKSA-N;8,9-dihydroxyicosa-5,11,14-trienoic acid;5,11,14-Eicosatrienoic acid, 8,9-dihydroxy-, (5Z,11Z,14Z)- | | CAS: | 192461-96-4 | | MF: | C20H34O4 | | MW: | 338.48 | | EINECS: | | | Product Categories: | | | Mol File: | 192461-96-4.mol |  |
| | (5Z,11Z,14Z)-8,9-dihydroxyicosa-5,11,14-trienoic acid Chemical Properties |
| Boiling point | 515.2±50.0 °C(Predicted) | | density | 1.025±0.06 g/cm3(Predicted) | | solubility | DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: 50 mg/ml; PBS pH 7.2: 1 mg/ml | | pka | 4.75±0.10(Predicted) |
| | (5Z,11Z,14Z)-8,9-dihydroxyicosa-5,11,14-trienoic acid Usage And Synthesis |
| Uses | (±)?-?8,?9-?DHET (8,9-Dihydroxyeicosatrienoic Acid) is associated with abnormal lipoprotein oxylipins and metabolic disorders and may contribute to chronic inflammation. | | Definition | ChEBI: A DHET obtained by formal dihydroxylation across the 8,9-double bond of arachidonic acid. |
| | (5Z,11Z,14Z)-8,9-dihydroxyicosa-5,11,14-trienoic acid Preparation Products And Raw materials |
|
